Skip to main content
. 2022 Oct 5;13:1002938. doi: 10.3389/fimmu.2022.1002938

Figure 2.

Figure 2

Overall survival of patients receiving the tumor cell-derived microparticles packaging methotrexate (TMPs-MTX) or saline combined with pemetrexed-cisplatin (PP) chemotherapy.